An interventional study of BQ and Sham in Acute Stroke, sponsored by BrainQ Technologies Ltd.. Terminated at 1 site in India. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2021-02-11.
Sponsored by BrainQ Technologies Ltd. · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 70 studies in Stroke with a site in India — 6 open to participants now, 9 under way, 4 of them phase 3. Stroke · India.
Among the 70 studies in Stroke with a site in India, this one is the 56th largest by enrollment of the 63 interventional ones that give a count, is one of 4 that started in 2018, is one of 19 with no phase, and was the 52nd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →6 of the 70 studies in Stroke with a site in India are open now. Recruiting first, the newest first:
Christian Medical College and Hospital, Ludhiana, India · Sites in India
Ages 18–99
Eli Lilly and Company · Sites in India, Argentina, Australia and 35 more countries
Ages 50+
Christian Medical College and Hospital, Ludhiana, India · Sites in India
Ages 18–99
Population Health Research Institute · Sites in India, United States, Argentina and 15 more countries
Ages 55+
Christian Medical College and Hospital, Ludhiana, India · Sites in India
Ages 18–99
A study can be open while its sites in India have not opened yet or have stopped. Only those recruiting at a site in India →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
70 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 7 · Phase 2 8 · Phase 3 24 · Phase 4 6
First in 1998; this study’s year is marked. 4 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 28 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 317 across the 63 interventional studies, 1,116 across the 7 observational. Of the 56 that completed or were terminated, 17 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
32 of 70 have an industry lead sponsor. The 10 most frequent:
BrainQ Technologies Ltd. is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
BrainQ Technologies Ltd. has 1 study filed under Stroke — fewer than ten, so there is no comparison to draw.
2 of the studies in Stroke with a site in India that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05836831Christian Medical College and Hospital, Ludhiana, IndiaIndian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage | 2026-11 |
| NCT05955326Pharmazz, Inc.Study to Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | 2026-12-18 |
Add all 2 to your calendar (.ics) → With an account.
Among the 70 studies in Stroke with a site in India, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study tests the efficacy of a non-invasive device with low intensity electromagnetic field dedicated treatment to enhance the recovery of stroke patients impaired hand motor function
The study investigates the effect of BCI based stimulation device on upper limb motor function of acute stroke patients.
The BQ device (BrainQ Technologies Ltd., Israel), a Brain Computer Interface based stimulation device, uses machine learning tools to identify high resolution spectral patterns associated with motor functions in EEG measurements of healthy/non healthy subjects. These patterns are then translated into a tailored frequency dependent low intensity, non-invasive electro-magnetic treatment protocol.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Able to sit in a chair for 70 consecutive minutes and follow three verbal instructions:
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Real BQ treatment, 40 treatments including 20 minutes of device guided functional motor tasks.
Device: BQ
Sham BQ treatment, (zero intensity) 40 treatments including 20 minutes of device guided functional motor tasks.
Device: Sham
The BQ device (BrainQ Technologies Ltd., Israel), a Brain Computer Interface based stimulation device, uses machine learning tools to identify high resolution spectral patterns associated with motor functions in EEG measurements of healthy/non healthy subjects. These patterns are then translated into a tailored frequency dependent low intensity, non-invasive electro-magnetic treatment protocol.
Also known as: Formerly VLIFE
Sham BQ device
Fugl Meyer Assessment of Upper Extremity (FMA-UE)
FMA score of upper limb, range between 0 to 66 (higher the better)
Time frame: Two months
ARAT
Action Research Arm test
Time frame: two months
BBT
Box and Blocks test
Time frame: two months
TMT
Trail making test
Time frame: two months
NIHSS
The national institutes of health stroke scale, a 0 to 42 scale, the higher the worse.
Time frame: two months
Promis 10
The PROMIS Global Health short form, 10 questions questionnaire, calculated through a look up t-score table
Time frame: two months
MoCA
Montreal cognitive assessment
Time frame: two months
mRs
modified Rankin scale, a 0 to 6 scale, the higher the worse
Time frame: two months
MRI-DTI
magnetic resonance imaging, diffusion tensor imaging
Time frame: two months
brain recovery biomarkers
UCH-L1, and GFAP
Time frame: two months
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2018 to primary completion in Mar 2020, 18 months.
How these figures are worked out, and which studies are left out of them.
This study is terminated, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
BrainQ Technologies Ltd.